MALIGNANT MELANOMA STAGE III

MALIGNANT MELANOMA STAGE III was reported 203 times

MALIGNANT MELANOMA STAGE III is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phosphodiesterase 5 Inhibitor [EPC] 60 0.0004
1 Sulfonamide Antibacterial [EPC] 1 0.0003
2 Provitamin D2 Compound [EPC] 5 0.0002
3 Integrin Receptor Antagonist [EPC] 9 0.0001
4 Quinolone Antimicrobial [EPC] 1 0.0001
5 Peroxisome Proliferator Receptor alpha Agonist [EPC] 4 0.0001
6 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 1 0.0001
7 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
8 Recombinant Human Deoxyribonuclease 1 [EPC] 1 0.0001
9 Thiazide-like Diuretic [EPC] 2 0.0000
10 Recombinant Human Growth Hormone [EPC] 1 0.0000
11 Pyrimidine Synthesis Inhibitor [EPC] 2 0.0000
12 Insulin [EPC] 2 0.0000
13 Sulfonylurea [EPC] 5 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000
15 Arteriolar Vasodilator [EPC] 3 0.0000
16 Alkaloid [EPC] 1 0.0000
17 Androgen [EPC] 1 0.0000
18 alpha-Adrenergic Blocker [EPC] 5 0.0000
19 Complement Inhibitor [EPC] 2 0.0000
20 Dihydropyridine Calcium Channel Blocker [EPC] 11 0.0000
21 Janus Kinase Inhibitor [EPC] 5 0.0000
22 Sympathomimetic-like Agent [EPC] 1 0.0000
23 Fluoroquinolone Antibacterial [EPC] 4 0.0000
24 Aminosalicylate [EPC] 3 0.0000
25 Opioid Agonist [EPC] 8 0.0000
26 Penem Antibacterial [EPC] 1 0.0000
27 Xanthine Oxidase Inhibitor [EPC] 5 0.0000
28 Interleukin-23 Antagonist [EPC] 3 0.0000
29 Tetracycline-class Drug [EPC] 2 0.0000
30 Potassium Channel Blocker [EPC] 2 0.0000
31 HMG-CoA Reductase Inhibitor [EPC] 10 0.0000
32 Calcium [EPC] 4 0.0000
33 Interferon beta [EPC] 5 0.0000
34 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
35 Thiazide Diuretic [EPC] 5 0.0000
36 beta-Adrenergic Blocker [EPC] 7 0.0000
37 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
38 Serotonin-3 Receptor Antagonist [EPC] 3 0.0000
39 Angiotensin 2 Receptor Blocker [EPC] 7 0.0000
40 Benzodiazepine [EPC] 15 0.0000
41 beta3-Adrenergic Agonist [EPC] 1 0.0000
42 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
43 Aldosterone Antagonist [EPC] 3 0.0000
44 Proton Pump Inhibitor [EPC] 11 0.0000
45 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
46 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
47 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
48 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
49 Estrogen [EPC] 3 0.0000
50 Atypical Antipsychotic [EPC] 7 0.0000
51 Nonsteroidal Anti-inflammatory Drug [EPC] 18 0.0000
52 Phosphodiesterase 4 Inhibitor [EPC] 2 0.0000
53 Tumor Necrosis Factor Blocker [EPC] 12 0.0000
54 Vitamin C [EPC] 5 0.0000
55 Platelet Aggregation Inhibitor [EPC] 6 0.0000
56 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
57 Osmotic Laxative [EPC] 3 0.0000
58 Acetylcholine Release Inhibitor [EPC] 1 0.0000
59 5-alpha Reductase Inhibitor [EPC] 1 0.0000
60 Interleukin-12 Antagonist [EPC] 1 0.0000
61 Antirheumatic Agent [EPC] 1 0.0000
62 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
63 Insulin Analog [EPC] 4 0.0000
64 Proteasome Inhibitor [EPC] 1 0.0000
65 Corticosteroid [EPC] 10 0.0000
66 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
67 Thalidomide Analog [EPC] 4 0.0000
68 GLP-1 Receptor Agonist [EPC] 3 0.0000
69 Loop Diuretic [EPC] 3 0.0000
70 Endothelin Receptor Antagonist [EPC] 1 0.0000
71 RANK Ligand Inhibitor [EPC] 1 0.0000
72 Expectorant [EPC] 1 0.0000
73 Mood Stabilizer [EPC] 1 0.0000
74 Anti-epileptic Agent [EPC] 1 0.0000
75 Alkylating Drug [EPC] 1 0.0000
76 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
77 Factor Xa Inhibitor [EPC] 1 0.0000
78 Vitamin D [EPC] 1 0.0000
79 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
80 Vitamin B12 [EPC] 1 0.0000
81 Kinase Inhibitor [EPC] 1 0.0000